N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 11.24 CNY 2.65% Market Closed
Market Cap: 18.2B CNY

Intrinsic Value

The intrinsic value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock under the Base Case scenario is 19.18 CNY. Compared to the current market price of 11.24 CNY, Nanjing King-friend Biochemical Pharmaceutical Co Ltd is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
19.18 CNY
Undervaluation 41%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Nanjing King-friend Biochemical Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
CN
Pharmaceuticals
Market Cap
18.2B CNY
IPO
Jul 19, 2017
CN
Pharmaceuticals
Market Cap
18.2B CNY
IPO
Jul 19, 2017
Price
ÂĄfalse
EPS
ÂĄfalse
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Current Assets 6.9B
Cash & Short-Term Investments 2B
Receivables 1.2B
Other Current Assets 3.8B
Non-Current Assets 2.5B
Long-Term Investments 81.9m
PP&E 1.2B
Intangibles 750.3m
Other Non-Current Assets 473.5m
Efficiency

Free Cash Flow Analysis
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Revenue
3.9B CNY
Cost of Revenue
-2.3B CNY
Gross Profit
1.6B CNY
Operating Expenses
-2B CNY
Operating Income
-392m CNY
Other Expenses
-30.9m CNY
Net Income
-423m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Negative Operating Income
51/100
Profitability
Score

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
74/100
Solvency
Score

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Wall Street analysts forecast Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is 19.04 CNY with a low forecast of 17.17 CNY and a high forecast of 21.36 CNY.

Lowest
Price Target
17.17 CNY
53% Upside
Average
Price Target
19.04 CNY
69% Upside
Highest
Price Target
21.36 CNY
90% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock?

The intrinsic value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock under the Base Case scenario is 19.18 CNY.

Is Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 11.24 CNY, Nanjing King-friend Biochemical Pharmaceutical Co Ltd is Undervalued by 41%.

Back to Top